Cerebral’s valuation quadruples to USD 4.8 billion after accumulating USD 300 million in a SoftBank funding round
Cerebral serves medication and therapy plans to treat depression, post-traumatic stress disorder, anxiety, substance abuse, and ...
Read moreDetails